Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21 Read More Analysis and Commentary STEVEN GROSSMAN 7/19/19 Analysis and Commentary STEVEN GROSSMAN 7/19/19 No Guarantees for a Bright Future Read More Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Put the Bubbly Back in the Fridge: No Budget Deal Quite Yet Read More Analysis and Commentary STEVEN GROSSMAN 7/12/19 Analysis and Commentary STEVEN GROSSMAN 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More Advocacy at a Glance STEVEN GROSSMAN 7/12/19 Advocacy at a Glance STEVEN GROSSMAN 7/12/19 House and Senate Action (or Lack) on FY 20 Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 6/29/19 Analysis and Commentary STEVEN GROSSMAN 6/29/19 What CBO Had to Say about Our Long-term Fiscal Health Read More Advocacy at a Glance STEVEN GROSSMAN 6/29/19 Advocacy at a Glance STEVEN GROSSMAN 6/29/19 House Passes H.R. 3055, Including Ag/FDA Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 6/24/19 Analysis and Commentary STEVEN GROSSMAN 6/24/19 Theory and Practice: How Appropriations Will Actually Work for FY 20 Read More Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Confused By the Budget and Appropriations Process? Read More Analysis and Commentary STEVEN GROSSMAN 5/31/19 Analysis and Commentary STEVEN GROSSMAN 5/31/19 The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy Read More Advocacy at a Glance STEVEN GROSSMAN 5/31/19 Advocacy at a Glance STEVEN GROSSMAN 5/31/19 House Appropriations To Move Quickly in June; Full-Committee Ag/FDA Mark-up on June 4 Read More Analysis and Commentary STEVEN GROSSMAN 5/23/19 Analysis and Commentary STEVEN GROSSMAN 5/23/19 House Mark-up for FY 20 Very Pleasing Read More Advocacy at a Glance STEVEN GROSSMAN 5/23/19 Advocacy at a Glance STEVEN GROSSMAN 5/23/19 House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding Read More Analysis and Commentary STEVEN GROSSMAN 5/17/19 Analysis and Commentary STEVEN GROSSMAN 5/17/19 Regular Order Appropriations: Enshrined in Law, but Not in Practice Read More Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Mixed Signals on Whether the White House Wants a Budget Deal Read More Analysis and Commentary STEVEN GROSSMAN 5/10/19 Analysis and Commentary STEVEN GROSSMAN 5/10/19 Potential Promise ... But Storm Clouds on Horizon Read More Advocacy at a Glance STEVEN GROSSMAN 5/10/19 Advocacy at a Glance STEVEN GROSSMAN 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More Analysis and Commentary STEVEN GROSSMAN 5/3/19 Analysis and Commentary STEVEN GROSSMAN 5/3/19 Federal Budgeting: A Brief Refresher Course Read More Advocacy at a Glance STEVEN GROSSMAN 5/3/19 Advocacy at a Glance STEVEN GROSSMAN 5/3/19 House Appropriations Subcommittees Begin FY 20 Bill Approvals Read More Analysis and Commentary STEVEN GROSSMAN 4/19/19 Analysis and Commentary STEVEN GROSSMAN 4/19/19 Gains and Gaps in Knowledge about Shutdown Processes Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21 Read More
Analysis and Commentary STEVEN GROSSMAN 7/19/19 Analysis and Commentary STEVEN GROSSMAN 7/19/19 No Guarantees for a Bright Future Read More
Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Put the Bubbly Back in the Fridge: No Budget Deal Quite Yet Read More
Analysis and Commentary STEVEN GROSSMAN 7/12/19 Analysis and Commentary STEVEN GROSSMAN 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More
Advocacy at a Glance STEVEN GROSSMAN 7/12/19 Advocacy at a Glance STEVEN GROSSMAN 7/12/19 House and Senate Action (or Lack) on FY 20 Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 6/29/19 Analysis and Commentary STEVEN GROSSMAN 6/29/19 What CBO Had to Say about Our Long-term Fiscal Health Read More
Advocacy at a Glance STEVEN GROSSMAN 6/29/19 Advocacy at a Glance STEVEN GROSSMAN 6/29/19 House Passes H.R. 3055, Including Ag/FDA Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 6/24/19 Analysis and Commentary STEVEN GROSSMAN 6/24/19 Theory and Practice: How Appropriations Will Actually Work for FY 20 Read More
Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Confused By the Budget and Appropriations Process? Read More
Analysis and Commentary STEVEN GROSSMAN 5/31/19 Analysis and Commentary STEVEN GROSSMAN 5/31/19 The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy Read More
Advocacy at a Glance STEVEN GROSSMAN 5/31/19 Advocacy at a Glance STEVEN GROSSMAN 5/31/19 House Appropriations To Move Quickly in June; Full-Committee Ag/FDA Mark-up on June 4 Read More
Analysis and Commentary STEVEN GROSSMAN 5/23/19 Analysis and Commentary STEVEN GROSSMAN 5/23/19 House Mark-up for FY 20 Very Pleasing Read More
Advocacy at a Glance STEVEN GROSSMAN 5/23/19 Advocacy at a Glance STEVEN GROSSMAN 5/23/19 House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding Read More
Analysis and Commentary STEVEN GROSSMAN 5/17/19 Analysis and Commentary STEVEN GROSSMAN 5/17/19 Regular Order Appropriations: Enshrined in Law, but Not in Practice Read More
Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Mixed Signals on Whether the White House Wants a Budget Deal Read More
Analysis and Commentary STEVEN GROSSMAN 5/10/19 Analysis and Commentary STEVEN GROSSMAN 5/10/19 Potential Promise ... But Storm Clouds on Horizon Read More
Advocacy at a Glance STEVEN GROSSMAN 5/10/19 Advocacy at a Glance STEVEN GROSSMAN 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More
Analysis and Commentary STEVEN GROSSMAN 5/3/19 Analysis and Commentary STEVEN GROSSMAN 5/3/19 Federal Budgeting: A Brief Refresher Course Read More
Advocacy at a Glance STEVEN GROSSMAN 5/3/19 Advocacy at a Glance STEVEN GROSSMAN 5/3/19 House Appropriations Subcommittees Begin FY 20 Bill Approvals Read More
Analysis and Commentary STEVEN GROSSMAN 4/19/19 Analysis and Commentary STEVEN GROSSMAN 4/19/19 Gains and Gaps in Knowledge about Shutdown Processes Read More
